G27919IH

Summary
GlyTouCan ID
G27919IH
IUPAC Condensed
GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc(b1-
Motifs
N-Glycan complex N-acetyllactosamine Type 2 LN
Subsumption Level
Fully-defined saccharide
Monoisotopic Mass
1624.6
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
CarbBank
1636 5096 7809 7811 7812 7813 7814 7815 7926 9029 9032 11511 11922 42692 45812 46616
GlycoGene Database (GGDB)
Displaying all 2 entries
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
MGAT3 UDP-GlcNAc
G27919IH
Asn-X
G85767HW
Asn-X
MGAT4A UDP-GlcNAc
G27919IH
Asn-X
G03445UI
Asn-X
KEGG BRITE Database
KEGG ID
References
GALAXY
Glucose Units
ODS
13.1
Amide
6.3
Degrading Enzymes
Displaying entries 1 - 5 of 8 in total
Enzyme Substrate Product
α-Fucosidase
G27919IH
G89993FE
α-Galactosidase
G56340GX
G27919IH
α-Glucuronidase
G34875XC
G27919IH
α-Sialidase
G63787RZ
G27919IH
α-Sialidase
G23295TF
G27919IH
Sequence Descriptors
GlycoCT
RES
1b:b-dglc-HEX-1:5
2s:n-acetyl
3b:b-dglc-HEX-1:5
4s:n-acetyl
5b:b-dman-HEX-1:5
6b:a-dman-HEX-1:5
7b:b-dglc-HEX-1:5
8s:n-acetyl
9b:a-dman-HEX-1:5
10b:b-dglc-HEX-1:5
11s:n-acetyl
12b:b-dgal-HEX-1:5
13b:a-lgal-HEX-1:5|6:d
LIN
1:1d(2+1)2n
2:1o(4+1)3d
3:3d(2+1)4n
4:3o(4+1)5d
5:5o(3+1)6d
6:6o(2+1)7d
7:7d(2+1)8n
8:5o(6+1)9d
9:9o(2+1)10d
10:10d(2+1)11n
11:10o(4+1)12d
12:1o(6+1)13d
WURCS
WURCS=2.0/5,9,8/[a2122h-1b_1-5_2*NCC/3=O][a1122h-1b_1-5][a1122h-1a_1-5][a2112h-1b_1-5][a1221m-1a_1-5]/1-1-2-3-1-3-1-4-5/a4-b1_a6-i1_b4-c1_c3-d1_c6-f1_d2-e1_f2-g1_g4-h1
Literature
Displaying entries 1 - 10 of 33 in total
PubMed ID Title First Author Publication Date Source
33242084 Post-natal developmental changes in the composition of the rat neocortical N-glycome Klarić Thomas S 2021-06-03
  • GlyGen
33383989 Bisecting GlcNAc Protein N-Glycosylation Is Characteristic of Human Adipogenesis Wongtrakul-Kish K 2021 Feb 5
  • GlyGen
30674035 Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis Costa J 2019 Jan 23
  • GlyGen
24680513 Comparison of separation techniques for the elucidation of IgG N-glycans pooled from healthy mammalian species Adamczyk B 2014 May 07
  • GlyGen
  • PubChem
24090084 Site-Specific Glycan-Peptide Analysis for Determination of N-Glycoproteome Heterogeneity Parker BL 2013 Dec 6
  • GlyGen
  • PubChem
20578731 Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia Stanta Johannes L 2010-09-03
  • GlyGen
14693911 Site-specific N-glycosylation of chicken serum IgG Suzuki Noriko 2004-03
  • GlyGen
12652077 Structural studies on IgG oligosaccharides of patients with primary Sjogren's syndrome Kuroda Y 2002 Jan
  • GlyGen
  • PubChem
11498595 Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design Saphire EO 2001 Aug 10
  • PubChem
10207177 Oligosaccharide analysis and molecular modeling of soluble forms of glycoproteins belonging to the Ly-6, scavenger receptor, and immunoglobulin superfamilies expressed in Chinese hamster ovary cells Rudd PM 1999 May
  • GlyGen
  • PubChem

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.4.0

Last updated: December 8, 2025